Home/Filings/4/0001209191-13-055081
4//SEC Filing

SPECTRUM PHARMACEUTICALS INC 4

Accession 0001209191-13-055081

CIK 0000831547operating

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 8:11 PM ET

Size

7.6 KB

Accession

0001209191-13-055081

Insider Transaction Report

Form 4
Period: 2013-12-03
Keller Joseph Kenneth
EVP & Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2013-12-03+100,000100,000 total
    Exercise: $9.62Exp: 2023-12-03Common Stock (100,000 underlying)
  • Award

    Common Stock, $0.001 par value

    2013-12-03+30,000168,000 total
Footnotes (2)
  • [F1]25% of the restricted shares vested on December 3, 2013. The remaining restricted shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.
  • [F2]25% of the option shares vested on December 3, 2013. The remaining option shares vest in equal 25% increments every 12 months on the anniversary date of the option award over 3 years.

Issuer

SPECTRUM PHARMACEUTICALS INC

CIK 0000831547

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000831547

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 8:11 PM ET
Size
7.6 KB